Localisation | Diagnosis | n | Mean IgG4/hpf | Range IgG4/hpf | Mean IgG/hpf | IgG4/IgG mean ratio | Range IgG4/IgG ratio |
Salivary glands | Sclerosing sialadenitis/Küttner tumour | 7 | 40 | 4–104 | 74 | 0.59 | 0.23–1 |
Sialadenitis caused by sialolithiasis | 11 | 3 | 0–26.8 | 54.0 | 0.02 | 0–0.15 | |
Oral cavity | All lesions | 27 | 79 | 0–235 | 235 | 0.32 | 0–0.84 |
Epulis plasmocellularis | 12 | 69 | 27–102 | 232 | 0.32 | 0.18–0.77 | |
Radicular cysts | 11 | 93 | 23.3–234 | 278 | 0.32 | 0.1–0.84 | |
Oral lichen ruber | 4 | 67 | 0–217 | 126 | 0.35 | 0–0.84 | |
Lower gastrointestinal tract | All lesions | 24 | 11 | 0–40 | 187 | 0.06 | 0–0.2 |
Crohn's disease | 9 | 8 | 1–22 | 160 | 0.046 | 0.008–0.08 | |
Ulcerative colitis | 9 | 8 | 0–18 | 210 | 0.04 | 0–0.06 | |
Diverticulitis | 6 | 19 | 0–40 | 194 | 0.11 | 0–0.2 | |
Synovitis | All lesions | 30 | 35 | 0–181 | 122 | 0.27 | 0–1 |
Rheumatoid arthritis | 15 | 55 | 0–181 | 153 | 0.4 | 0–1 | |
Non-specific synovitis | 15 | 15 | 0–79 | 92 | 0.15 | 0–0.44 | |
Carcinomas | All lesions | 21 | 24 | 0–88 | 117 | 0.22 | 0–0.51 |
Adenocarcinomas | 10 | 6 | 0–88 | 73 | 0.21 | 0–0.48 | |
Squamous cell carcinomas | 11 | 34 | 1–81 | 156 | 0.23 | 0–0.51 | |
Skin | All lesions | 8 | 26 | 1–120 | 85 | 0.21 | 0.04–0.67 |
hpf, high-power field.